The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.
 
Marianna Nuti
No Relationships to Disclose
 
Ilaria Zizzari
No Relationships to Disclose
 
Chiara Napoletano
No Relationships to Disclose
 
Andrea Botticelli
No Relationships to Disclose
 
Fabio Calabro
Consulting or Advisory Role - Novartis; Pfizer
 
Alain Gelibter
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck
 
Aurelia Rughetti
No Relationships to Disclose
 
Alessio Ugolini
No Relationships to Disclose
 
Ilary Ruscito
No Relationships to Disclose
 
Federica Mazzuca
No Relationships to Disclose
 
Hassan Rahimi
No Relationships to Disclose
 
Concetta Elisa Onesti
No Relationships to Disclose
 
Enrico Cortesi
Honoraria - Janssen
Consulting or Advisory Role - Sirtex Medical
 
Paolo Marchetti
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Molteni Farmaceutici; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Molteni Farmaceutici (Inst); Roche (Inst)